{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:36:22Z","timestamp":1791689782963,"version":"4.3.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007063","name":"University of Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11302-025-10124-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:17:49Z","timestamp":1770279469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A2AR antagonist IDPU facilitates the restoration of mitochondrial dynamics in 6-OHDA-induced primary mid-brain neuronal cells, via regulating p38MAPK\/Parkin\/DJ-1\/DRP1 axis"],"prefix":"10.1007","volume":"22","author":[{"given":"Vaishali","family":"Walecha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuithung","family":"Sophronea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratibha Mehta","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"10124_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1196\/annals.1332.015","volume":"1035","author":"P Vernier","year":"2004","unstructured":"Vernier P, Moret F, Callier S, Snapyan M, Wersinger C, Sidhu A (2004) The degeneration of dopamine neurons in Parkinson\u2019s disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci 1035(1):231\u2013249","journal-title":"Ann N Y Acad Sci"},{"key":"10124_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11064-007-9482-y","volume":"33","author":"IG Onyango","year":"2008","unstructured":"Onyango IG (2008) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Neurochem Res 33:589\u2013597","journal-title":"Neurochem Res"},{"issue":"381","key":"10124_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","volume":"15","author":"K Kaur","year":"2017","unstructured":"Kaur K, Gill JS, Bansal PK, Deshmukh R (2017) Neuroinflammation-a major cause for striatal dopaminergic degeneration in Parkinson\u2019s disease. J Neurol Sci 15(381):308\u2013314","journal-title":"J Neurol Sci"},{"issue":"4","key":"10124_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2016.03.038","volume":"90","author":"PP Michel","year":"2016","unstructured":"Michel PP, Hirsch EC, Hunot S (2016) Understanding dopaminergic cell death pathways in Parkinson\u2019s disease. Neuron 90(4):675\u2013691","journal-title":"Neuron"},{"issue":"3","key":"10124_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1042\/BJ20110949","volume":"439","author":"AJ Morgan","year":"2011","unstructured":"Morgan AJ, Platt FM, Lloyd-Evans E, Galione A (2011) Molecular mechanisms of endolysosomal Ca2+ signalling in health and disease. Biochemical Journal 439(3):349\u2013378","journal-title":"Biochemical Journal"},{"issue":"3\u20134","key":"10124_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0926-6917(95)90040-3","volume":"292","author":"YY Glinka","year":"1995","unstructured":"Glinka YY, Youdim MB (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol Environ Toxicol Pharm 292(3\u20134):329\u2013332","journal-title":"Eur J Pharmacol Environ Toxicol Pharm"},{"issue":"2","key":"10124_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/jbcpp-2019-0270","volume":"32","author":"L Elyasi","year":"2021","unstructured":"Elyasi L, Jahanshahi M, Jameie SB, Hamid Abadi HG, Nikmahzar E, Khalili M, Jameie M, Jameie M (2021) 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson\u2019s disease suppressed by pretreatment with hesperidin through activating L-type calcium channels. J Basic Clin Physiol Pharmacol 32(2):11\u201317","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"2","key":"10124_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12640-018-9976-1","volume":"35","author":"NF Marques","year":"2019","unstructured":"Marques NF, Massari CM, Tasca CI (2019) Guanosine protects striatal slices against 6-OHDA-induced oxidative damage, mitochondrial dysfunction, and ATP depletion. Neurotox Res 35(2):475\u2013483","journal-title":"Neurotox Res"},{"issue":"12","key":"10124_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3389\/fnins.2018.00342","volume":"23","author":"S Franco-Iborra","year":"2018","unstructured":"Franco-Iborra S, Vila M, Perier C (2018) Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease. Front Neurosci 23(12):342","journal-title":"Front Neurosci"},{"issue":"1","key":"10124_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1152\/physrev.00005.2018","volume":"99","author":"\u00c5B Gustafsson","year":"2019","unstructured":"Gustafsson \u00c5B, Dorn GW (2019) Evolving and expanding the roles of mitophagy as a homeostatic and pathogenic process. Physiol Rev 99(1):853\u2013892","journal-title":"Physiol Rev"},{"issue":"1","key":"10124_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi G, Schwarz TL (2013) The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ 20(1):31\u201342","journal-title":"Cell Death Differ"},{"issue":"1","key":"10124_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, Zeng Y, Cai J, Zhang DW, Zhao G (2023) The mitophagy pathway and its implications in human diseases. Signal Transduct Target Ther 8(1):304","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10124_CR13","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani S, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M, Khoshnam SE (2023) Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem Res 48(8):2285\u20132308","journal-title":"Neurochem Res"},{"issue":"8","key":"10124_CR14","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/sj.cdd.4401960","volume":"13","author":"P Pinton","year":"2006","unstructured":"Pinton P, Rizzuto R (2006) Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum. Cell Death Differ 13(8):1409\u20131418","journal-title":"Cell Death Differ"},{"issue":"1","key":"10124_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1471-4159.2006.03730.x","volume":"97","author":"M Ouyang","year":"2006","unstructured":"Ouyang M, Shen X (2006) Critical role of ASK1 in the 6\u2010hydroxydopamine\u2010induced apoptosis in human neuroblastoma SH\u2010SY5Y cells. J Neurochem 97(1):234\u2013244","journal-title":"J Neurochem"},{"issue":"1","key":"10124_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20021641","volume":"372","author":"RM Biondi","year":"2003","unstructured":"Biondi RM, Nebreda AR (2003) Signalling specificity of Ser\/Thr protein kinases through docking-site-mediated interactions. Biochemical Journal 372(1):1\u20133","journal-title":"Biochemical Journal"},{"issue":"26","key":"10124_CR17","doi-asserted-by":"publisher","first-page":"18793","DOI":"10.1074\/jbc.M611252200","volume":"282","author":"DC Wright","year":"2007","unstructured":"Wright DC, Geiger PC, Han DH, Jones TE, Holloszy JO (2007) Calcium increases peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 and mitochondrial biogenesis by a pathway leading to p38 mitogen-activated protein kinase activation. J Biol Chem 282(26):18793\u201318799","journal-title":"J Biol Chem"},{"issue":"11","key":"10124_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.redox.2016.12.008","volume":"1","author":"CJ Hwang","year":"2017","unstructured":"Hwang CJ, Kim YE, Son DJ, Park MH, Choi DY, Park PH, Hellstr\u00f6m M, Han SB, Oh KW, Park EK, Hong JT (2017) Parkin deficiency exacerbates ethanol-induced dopaminergic neurodegeneration by P38 pathway-dependent inhibition of autophagy and mitochondrial function. Redox Biol 1(11):456\u2013468","journal-title":"Redox Biol"},{"issue":"13","key":"10124_CR19","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1074\/jbc.M110.144238","volume":"286","author":"H Wang","year":"2011","unstructured":"Wang H, Song P, Du L, Tian W, Yue W, Liu M, Li D, Wang B, Zhu Y, Cao C, Zhou J (2011) Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson\u2019s disease. J Biol Chem 286(13):11649\u201311658","journal-title":"J Biol Chem"},{"key":"10124_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8474303","volume":"1","author":"J Tang","year":"2016","unstructured":"Tang J, Hu Z, Tan J, Yang S, Zeng L (2016) Parkin protects against oxygen\u2010glucose deprivation\/reperfusion insult by promoting Drp1 degradation. Oxid Med Cell Longev 1:8474303","journal-title":"Oxid Med Cell Longev"},{"issue":"34","key":"10124_CR21","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.1610099113","volume":"113","author":"W Wang","year":"2016","unstructured":"Wang W, Nguyen LT, Burlak C, Chegini F, Guo F, Chataway T, Ju S, Fisher OS, Miller DW, Datta D, Wu F (2016) Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein. Proc Natl Acad Sci 113(34):9587\u20139592","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10124_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1523\/JNEUROSCI.3365-12.2013","volume":"33","author":"DB Wang","year":"2013","unstructured":"Wang DB, Garden GA, Kinoshita C, Wyles C, Babazadeh N, Sopher B, Kinoshita Y, Morrison RS (2013) Declines in Drp1 and parkin expression underlie DNA damage-induced changes in mitochondrial length and neuronal death. J Neurosci 33(4):1357\u20131365","journal-title":"J Neurosci"},{"issue":"10","key":"10124_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.524","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zhang Q, Zhang P, Sun L, Peng C, Yuan Z, Cheng J (2017) c-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death. Cell Death Dis 8(10):e3117","journal-title":"Cell Death Dis"},{"issue":"388","key":"10124_CR24","doi-asserted-by":"publisher","first-page":"114874","DOI":"10.1016\/j.taap.2019.114874","volume":"1","author":"C Gui","year":"2020","unstructured":"Gui C, Ren Y, Chen J, Wu X, Mao K, Li H, Yu H, Zou F, Li W (2020) p38 MAPK-DRP1 signalling is involved in mitochondrial dysfunction and cell death in mutant A53T \u03b1-synuclein model of Parkinson\u2019s disease. Toxicol Appl Pharmacol 1(388):114874","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10124_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-018-0722-7","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Ren Y, Gui C, Zhao M, Wu X, Mao K, Li W, Zou F (2018) Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T \u03b1-synuclein model of Parkinson\u2019s disease. Cell Death Dis 9(6):700","journal-title":"Cell Death Dis"},{"issue":"15","key":"10124_CR26","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.2174\/138161208784480108","volume":"14","author":"S Ferre","year":"2008","unstructured":"Ferre S, Quiroz C, Woods AS, Cunha R, Popoli P, Ciruela F, Lluis C, Franco R, Azdad K, Schiffmann SN (2008) An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors. Curr Pharm Des 14(15):1468\u20131474","journal-title":"Curr Pharm Des"},{"issue":"7","key":"10124_CR27","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","volume":"26","author":"F Ciruela","year":"2006","unstructured":"Ciruela F, Casad\u00f3 V, Rodrigues RJ, Luj\u00e1n R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cort\u00e9s A (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1\u2013A2A receptor heteromers. J Neurosci 26(7):2080\u20132087","journal-title":"J Neurosci"},{"issue":"3","key":"10124_CR28","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s12035-022-03162-1","volume":"60","author":"FQ Gon\u00e7alves","year":"2023","unstructured":"Gon\u00e7alves FQ, Matheus FC, Silva HB, Real JI, Rial D, Rodrigues RJ, Oses JP, Silva AC, Gon\u00e7alves N, Prediger RD, Tom\u00e9 \u00c2R (2023) Increased ATP release and higher impact of adenosine A2A receptors on corticostriatal plasticity in a rat model of presymptomatic Parkinson\u2019s disease. Mol Neurobiol 60(3):1659\u20131674","journal-title":"Mol Neurobiol"},{"issue":"9","key":"10124_CR29","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.3390\/ijms25094903","volume":"25","author":"AC Nunes","year":"2024","unstructured":"Nunes AC, Carmo M, Behrenswerth A, Canas PM, Agostinho P, Cunha RA (2024) Adenosine A2A receptor blockade provides more effective benefits at the onset rather than after overt neurodegeneration in a rat model of Parkinson\u2019s disease. Int J Mol Sci 25(9):4903","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10124_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.nbd.2007.04.018","volume":"27","author":"CG Silva","year":"2007","unstructured":"Silva CG, Porci\u00fancula LO, Canas PM, Oliveira CR, Cunha RA (2007) Blockade of adenosine A2A receptors prevents staurosporine-induced apoptosis of rat hippocampal neurons. Neurobiol Dis 27(2):182\u2013189","journal-title":"Neurobiol Dis"},{"issue":"15","key":"10124_CR31","doi-asserted-by":"publisher","first-page":"137610","DOI":"10.1016\/j.neulet.2023.137610","volume":"826","author":"Q Hu","year":"2024","unstructured":"Hu Q, Xu L, Liu X, Wang Y, Yuan J (2024) Adenosine A2A receptor antagonist KW6002 protects against A53T mutant alpha-synuclein-induced brain damage and neuronal apoptosis in Parkinson\u2019s disease mice by restoring autophagic flux. Neurosci Lett 826(15):137610","journal-title":"Neurosci Lett"},{"issue":"47","key":"10124_CR32","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1523\/JNEUROSCI.3728-09.2009","volume":"29","author":"PM Canas","year":"2009","unstructured":"Canas PM, Porci\u00fancula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009) Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by \u03b2-amyloid peptides via p38 mitogen-activated protein kinase pathway. J Neurosci 29(47):14741\u201314751","journal-title":"J Neurosci"},{"issue":"10","key":"10124_CR33","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1080\/09168451.2019.1627181","volume":"83","author":"H Ren","year":"2019","unstructured":"Ren H, Guo X, Wang X, Cui Z (2019) Adenosine A2A receptor deficiency prevents p38MAPK activation and apoptosis of mouse hippocampal cells in the chronic hypoxic-hypercapnia model. Biosci Biotechnol Biochem 83(10):1837\u20131842","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"10124_CR34","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bmcl.2009.11.133","volume":"20","author":"PM Luthra","year":"2010","unstructured":"Luthra PM, Mishra CB, Jha PK, Barodia SK (2010) Synthesis of novel 7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4, 5-d] pyrimidine derivatives as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 20(3):1214\u20131218","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10124_CR35","doi-asserted-by":"publisher","first-page":"130242","DOI":"10.1016\/j.bbagen.2022.130242","volume":"1866","author":"SK Barodia","year":"2022","unstructured":"Barodia SK, Sophronea T, Luthra PM (2022) A2A R-mediated modulation in IP3 levels, altering the [Ca2+] i through cAMP-dependent PKA signalling pathway. Biochimica et Biophysica Acta (BBA)-General Subjects 1866(12):130242","journal-title":"Biochimica et Biophysica Acta (BBA)-General Subjects"},{"key":"10124_CR36","doi-asserted-by":"publisher","first-page":"105793","DOI":"10.1016\/j.neuint.2024.105793","volume":"15","author":"T Sophronea","year":"2024","unstructured":"Sophronea T, Agrawal S, Kumari N, Mishra J, Walecha V, Luthra PM (2024) A2AR antagonists triggered the AMPK\/m-TOR autophagic pathway to reverse the calcium-dependent cell damage in 6-OHDA induced model of PD. Neurochem Int 15:105793","journal-title":"Neurochem Int"},{"issue":"24","key":"10124_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2017.03.033","volume":"647","author":"N Kumari","year":"2017","unstructured":"Kumari N, Agrawal S, Luthra PM (2017) Pharmacological assessments of potent A2A receptor antagonist IDPU (1-(7-imino-3-propyl-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-6 (7H)-yl) urea) in a rodent model of haloperidol induced Parkinson like symptoms. Neurosci Lett 647(24):53\u201360","journal-title":"Neurosci Lett"},{"issue":"14","key":"10124_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2018.03.040","volume":"675","author":"N Kumari","year":"2018","unstructured":"Kumari N, Agrawal S, Kumari R, Sharma D, Luthra PM (2018) Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-6 (7H)-yl) urea) in 6-OHDA-induced rodent model of hemiparkinson\u2019s disease. Neurosci Lett 675(14):74\u201382","journal-title":"Neurosci Lett"},{"issue":"19","key":"10124_CR39","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/j.bmc.2013.07.005","volume":"21","author":"CB Mishra","year":"2013","unstructured":"Mishra CB, Sharma D, Prakash A, Kumari N, Kumar N, Luthra PM (2013) Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2, 3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists. Bioorg Med Chem 21(19):6077\u20136083","journal-title":"Bioorg Med Chem"},{"key":"10124_CR40","doi-asserted-by":"publisher","DOI":"10.3791\/51751","volume":"91","author":"F Gaven","year":"2014","unstructured":"Gaven F, Marin P, Claeysen S (2014) Primary culture of mouse dopaminergic neurons. J Vis Exp (JoVE) 91:e51751. https:\/\/doi.org\/10.3791\/51751","journal-title":"J Vis Exp (JoVE)"},{"key":"10124_CR41","doi-asserted-by":"crossref","unstructured":"Mishra J, Walecha V, Sophronea T, Singh A, Agrawal S, Luthra PM (2024) BBPT attenuated 6-OHDA-induced toxicity by modulating oxidative stress, apoptotic, and inflammatory proteins in primary neurons and rat models of Parkinson\u2019s disease. NeuroToxicology 105:67-81","DOI":"10.1016\/j.neuro.2024.08.008"},{"issue":"1","key":"10124_CR42","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1038\/s41598-021-90845-9","volume":"11","author":"VS Christina","year":"2021","unstructured":"Christina VS, Sundaram RL, Sivamurugan V, Kumar DT, Mohanapriya CD, Shailaja VL, Thyagarajan SP, Doss CG, Gnanambal KM (2021) Inhibition of MMP2-PEX by a novel ester of dihydroxy cinnamic and linoleic acid from the seagrass Cymodocea serrulata. Sci Rep 11(1):11451","journal-title":"Sci Rep"},{"issue":"4","key":"10124_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3(4):461\u2013491","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"10124_CR44","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","volume":"102","author":"MA Eldeeb","year":"2022","unstructured":"Eldeeb MA, Thomas RA, Ragheb MA, Fallahi A, Fon EA (2022) Mitochondrial quality control in health and in Parkinson\u2019s disease. Physiol Rev 102(4):1721\u20131755","journal-title":"Physiol Rev"},{"key":"10124_CR45","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12640-020-00213-0","volume":"38","author":"E Anis","year":"2020","unstructured":"Anis E, Zafeer MF, Firdaus F, Islam SN, Khan AA, Hossain MM (2020) Perillyl alcohol mitigates behavioral changes and limits cell death and mitochondrial changes in unilateral 6-OHDA lesion model of Parkinson\u2019s disease through alleviation of oxidative stress. Neurotox Res 38:461\u2013477","journal-title":"Neurotox Res"},{"issue":"19","key":"10124_CR46","doi-asserted-by":"publisher","first-page":"20451","DOI":"10.1074\/jbc.M311164200","volume":"279","author":"WS Choi","year":"2004","unstructured":"Choi WS, Eom DS, Han BS, Kim WK, Han BH, Choi EJ, Oh TH, Markelonis GJ, Cho JW, Oh YJ (2004) Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8-and-9-mediated apoptotic pathways in dopaminergic neurons. J Biol Chem 279(19):20451\u201320460","journal-title":"J Biol Chem"},{"issue":"8","key":"10124_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.320","volume":"5","author":"S Saez-Atienzar","year":"2014","unstructured":"Saez-Atienzar S, Bonet-Ponce L, Blesa JR, Romero FJ, Murphy MP, Jordan J, Galindo MF (2014) The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling. Cell Death Dis 5(8):e1368","journal-title":"Cell Death Dis"},{"issue":"10","key":"10124_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0318-z","volume":"51","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Hu C, Huang J, Liu W, Lai W, Leng F, Tang Q, Liu Y, Wang Q, Zhou M, Sheng F (2019) ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson\u2019s disease. Exp Mol Med 51(10):1\u20133","journal-title":"Exp Mol Med"},{"key":"10124_CR49","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/jnc.13618","volume":"139","author":"BH Falkenburger","year":"2016","unstructured":"Falkenburger BH, Saridaki T, Dinter E (2016) Cellular models for Parkinson\u2019s disease. J Neurochem 139:121\u2013130","journal-title":"J Neurochem"},{"issue":"9","key":"10124_CR50","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1074\/jbc.M511560200","volume":"281","author":"K Hanrott","year":"2006","unstructured":"Hanrott K, Gudmunsen L, O\u2019Neill MJ, Wonnacott S (2006) 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase C\u03b4. J Biol Chem 281(9):5373\u20135382","journal-title":"J Biol Chem"},{"issue":"3","key":"10124_CR51","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.taap.2011.07.021","volume":"256","author":"C Latchoumycandane","year":"2011","unstructured":"Latchoumycandane C, Anantharam V, Jin H, Kanthasamy A, Kanthasamy A (2011) Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKC\u03b4 in cell culture and animal models of Parkinson\u2019s disease. Toxicol Appl Pharmacol 256(3):314\u2013323","journal-title":"Toxicol Appl Pharmacol"},{"issue":"110","key":"10124_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2016.07.012","volume":"1","author":"WK Ko","year":"2016","unstructured":"Ko WK, Camus SM, Li Q, Yang J, McGuire S, Pioli EY, Bezard E (2016) An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated macaque models. Neuropharmacology 1(110):48\u201358","journal-title":"Neuropharmacology"},{"issue":"728","key":"10124_CR53","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejphar.2014.01.052","volume":"5","author":"KM Smith","year":"2014","unstructured":"Smith KM, Browne SE, Jayaraman S, Bleickardt CJ, Hodge LM, Lis E, Yao L, Rittle SL, Innocent N, Mullins DE, Boykow G (2014) Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice. Eur J Pharmacol 5(728):31\u201338","journal-title":"Eur J Pharmacol"},{"issue":"110","key":"10124_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuropharm.2016.04.017","volume":"1","author":"CY Lin","year":"2016","unstructured":"Lin CY, Tsai CW (2016) Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of the parkin pathway. Neuropharmacology 1(110):109\u2013117","journal-title":"Neuropharmacology"},{"issue":"1","key":"10124_CR55","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1038\/s41598-017-07142-7","volume":"7","author":"SF Wang","year":"2017","unstructured":"Wang SF, Liu LF, Wu MY, Cai CZ, Su H, Tan J, Lu JH, Li M (2017) Baicalein prevents 6-OHDA\/ascorbic acid-induced calcium-dependent dopaminergic neuronal cell death. Sci Rep 7(1):8398","journal-title":"Sci Rep"},{"issue":"11","key":"10124_CR56","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1080\/15548627.2018.1493043","volume":"14","author":"Y Urano","year":"2018","unstructured":"Urano Y, Mori C, Fuji A, Konno K, Yamamoto T, Yashirogi S, Ando M, Saito Y, Noguchi N (2018) 6-Hydroxydopamine induces secretion of PARK7\/DJ-1 via autophagy-based unconventional secretory pathway. Autophagy 14(11):1943\u20131958","journal-title":"Autophagy"},{"issue":"3","key":"10124_CR57","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.freeradbiomed.2007.04.028","volume":"43","author":"SM Kulich","year":"2007","unstructured":"Kulich SM, Horbinski C, Patel M, Chu CT (2007) 6-hydroxydopamine induces mitochondrial ERK activation. Free Radical Biol Med 43(3):372\u2013383","journal-title":"Free Radical Biol Med"},{"key":"10124_CR58","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00702-014-1185-3","volume":"121","author":"A Kupsch","year":"2014","unstructured":"Kupsch A, Schmidt W, Gizatullina Z, Debska-Vielhaber G, Voges J, Striggow F, Panther P, Schwegler H, Heinze HJ, Vielhaber S, Gellerich FN (2014) 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson\u2019s disease: respirometric, histological, and behavioral analyses. J Neural Transm 121:1245\u20131257","journal-title":"J Neural Transm"},{"issue":"208","key":"10124_CR59","doi-asserted-by":"publisher","first-page":"108981","DOI":"10.1016\/j.neuropharm.2022.108981","volume":"1","author":"G Fang","year":"2022","unstructured":"Fang G, Zhou Y, Zhou X, Zhou H, Ge YY, Luo S, Chen JF, Zhang L (2022) The adenosine A2A receptor antagonist protects against retinal mitochondrial injury in association with an altered network of competing endogenous RNAs. Neuropharmacology 1(208):108981","journal-title":"Neuropharmacology"},{"issue":"4","key":"10124_CR60","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1096\/fj.201902459R","volume":"34","author":"CM Castro","year":"2020","unstructured":"Castro CM, Corciulo C, Solesio ME, Liang F, Pavlov EV, Cronstein BN (2020) Adenosine A2A receptor (A2AR) stimulation enhances mitochondrial metabolism and mitigates reactive oxygen species\u2010mediated mitochondrial injury. FASEB J 34(4):5027\u20135045","journal-title":"FASEB J"},{"issue":"11","key":"10124_CR61","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","volume":"10","author":"GK Ganjam","year":"2019","unstructured":"Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, H\u00f6llerhage M, H\u00f6glinger GU, Adamczyk A, Decher N, Oertel WH, Culmsee C (2019) Mitochondrial damage by \u03b1-synuclein causes cell death in human dopaminergic neurons. Cell Death Dis 10(11):865","journal-title":"Cell Death Dis"},{"issue":"7","key":"10124_CR62","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1523\/JNEUROSCI.21-07-02247.2001","volume":"21","author":"A Hartmann","year":"2001","unstructured":"Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y, Hirsch EC (2001) Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease, but pathway inhibition results in neuronal necrosis. J Neurosci 21(7):2247\u20132255","journal-title":"J Neurosci"},{"issue":"12","key":"10124_CR63","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/ijms21124455","volume":"21","author":"RT Tsai","year":"2020","unstructured":"Tsai RT, Tsai CW, Liu SP, Gao JX, Kuo YH, Chao PM, Hung HS, Shyu WC, Lin SZ, Fu RH (2020) Maackiain ameliorates 6-hydroxydopamine an","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10124_CR64","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1038\/s41598-017-07181-0","volume":"7","author":"S Bido","year":"2017","unstructured":"Bido S, Soria FN, Fan RZ, Bezard E, Tieu K (2017) Mitochondrial division inhibitor-1 is neuroprotective in the A53T-\u03b1-synuclein rat model of Parkinson\u2019s disease. Sci Rep 7(1):7495","journal-title":"Sci Rep"},{"issue":"15","key":"10124_CR65","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.3390\/ijms20153727","volume":"20","author":"M Okada","year":"2019","unstructured":"Okada M, Fukuyama K, Shiroyama T, Ueda Y (2019) Carbamazepine attenuates astroglial l-glutamate release induced by pro-inflammatory cytokines via chronically activation of adenosine A2A receptor. Int J Mol Sci 20(15):3727","journal-title":"Int J Mol Sci"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-025-10124-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-025-10124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:04:26Z","timestamp":1771884266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-025-10124-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10124"],"URL":"https:\/\/doi.org\/10.1007\/s11302-025-10124-4","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project was approved by the Departmental Animal Ethics Committee on  21\u2009st August 2023 for both in vitro (isolation of primary midbrain neuronal cells from\n                      P\n                      0\n                      \/\n                      P\n                      1\n                      pups of SD rats) and in vivo studies under proposal no. IAEC\/ACBR\/August 2023\/PML\/02.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"18"}}